Post‐acute COVID‐19 syndrome (PCS) and health‐related quality of life (HRQoL)—A systematic review and meta‐analysis
There is an established literature on the symptoms and complications of COVID‐19 but the
after‐effects of COVID‐19 are not well understood with few studies reporting persistent …
after‐effects of COVID‐19 are not well understood with few studies reporting persistent …
Unraveling the mystery surrounding post-acute sequelae of COVID-19
RK Ramakrishnan, T Kashour, Q Hamid… - Frontiers in …, 2021 - frontiersin.org
More than one year since its emergence, corona virus disease 2019 (COVID-19) is still
looming large with a paucity of treatment options. To add to this burden, a sizeable subset of …
looming large with a paucity of treatment options. To add to this burden, a sizeable subset of …
Symptom prevalence, duration, and risk of hospital admission in individuals infected with SARS-CoV-2 during periods of omicron and delta variant dominance: a …
Summary Background The SARS-CoV-2 variant of concern, omicron, appears to be less
severe than delta. We aim to quantify the differences in symptom prevalence, risk of hospital …
severe than delta. We aim to quantify the differences in symptom prevalence, risk of hospital …
Association of COVID-19 with short-and long-term risk of cardiovascular disease and mortality: a prospective cohort in UK Biobank
Aims This study aims to evaluate the short-and long-term associations between COVID-19
and development of cardiovascular disease (CVD) outcomes and mortality in the general …
and development of cardiovascular disease (CVD) outcomes and mortality in the general …
COVID-19-associated opportunistic infections: a snapshot on the current reports
Abstract Treatment of the novel Coronavirus Disease 2019 (COVID-19) remains a
complicated challenge, especially among patients with severe disease. In recent studies …
complicated challenge, especially among patients with severe disease. In recent studies …
Allogenic mesenchymal stromal cells and their extracellular vesicles in COVID-19 induced ARDS: a randomized controlled trial
Background and aims The main causes of death in patients with severe Coronavirus
disease-2019 (COVID-19) are acute respiratory distress syndrome (ARDS) and multiorgan …
disease-2019 (COVID-19) are acute respiratory distress syndrome (ARDS) and multiorgan …
The mechanism underlying extrapulmonary complications of the coronavirus disease 2019 and its therapeutic implication
Q Ning, D Wu, X Wang, D Xi, T Chen, G Chen… - Signal transduction and …, 2022 - nature.com
Abstract The coronavirus disease 2019 (COVID-19) is a highly transmissible disease
caused by the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) that poses a …
caused by the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) that poses a …
Application of artificial intelligence and machine learning for COVID-19 drug discovery and vaccine design
The global pandemic of coronavirus disease 2019 (COVID-19), caused by severe acute
respiratory syndrome coronavirus 2, has led to a dramatic loss of human life worldwide …
respiratory syndrome coronavirus 2, has led to a dramatic loss of human life worldwide …
Endothelial dysfunction contributes to severe COVID-19 in combination with dysregulated lymphocyte responses and cytokine networks
L Ruhl, I Pink, JF Kühne, K Beushausen… - Signal transduction and …, 2021 - nature.com
The systemic processes involved in the manifestation of life-threatening COVID-19 and in
disease recovery are still incompletely understood, despite investigations focusing on the …
disease recovery are still incompletely understood, despite investigations focusing on the …
Covid-19 infection in India: a comparative analysis of the second wave with the first wave
A Sarkar, AK Chakrabarti, S Dutta - Pathogens, 2021 - mdpi.com
Coronavirus disease 2019 (COVID-19) is considered as the most dreaded disease that has
spread all over the world in the recent past. Despite its outbreak in December 2019–January …
spread all over the world in the recent past. Despite its outbreak in December 2019–January …